Sandip Basu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Neuroendocrine Tumors

Contrast Enhanced

Top Venues

World journal of nuclear medicine

Journal of clinical medicine

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Parth Baberwal, Sunita Nitin Sonavane, Sandip Basu
18 F-Fluorodeoxyglucose Uptake in Bilateral Diaphragmatic Crura: A Relatively Uncommon Benign Variant Noted in a Treated Case of Extraosseous Paraspinal Ewing's Sarcoma. World journal of nuclear medicine 23 (1) (2024)
Nivedita Chakrabarty, Abhishek Mahajan, Sandip Basu, Anil K D'Cruz
Comprehensive Review of the Imaging Recommendations for Diagnosis, Staging, and Management of Thyroid Carcinoma. Journal of clinical medicine 13 (10) (2024)
Rahul V Parghane, Sandip Basu
Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by 68 Ga-PSMA-11 PET/CT Imaging at Initial Staging. World journal of nuclear medicine 23 (1) (2024)
Parth Baberwal, Sunita Nitin Sonavane, Sandip Basu
18 F-Fluorodeoxyglucose Uptake in Bilateral Diaphragmatic Crura: A Relatively Uncommon Benign Variant Noted in a Treated Case of Extraosseous Paraspinal Ewing's Sarcoma. World journal of nuclear medicine 23 (1) (2024)
Sunita Nitin Sonavane, Tukaram Jamale, Sreyasi Bose, Sandip Basu
Febrile Immunocompromised Renal Transplant Recipient with Allograft Dysfunction: Detection of an Undiagnosed Prostate Abscess by [ 18 F]FDG-PET/CT along with Treatment Response Monitoring. World journal of nuclear medicine 23 (3) (2024)
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of 131 I-Whole-Body Scintigraphy with Regional SPECT/CT. World journal of nuclear medicine 23 (2) (2024)
Rahul V Parghane, Sandip Basu
Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by 68 Ga-PSMA-11 PET/CT Imaging at Initial Staging. World journal of nuclear medicine 23 (1) (2024)
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors. World journal of nuclear medicine 23 (3) (2024)
Sunita Nitin Sonavane, Tukaram Jamale, Sreyasi Bose, Sandip Basu
Febrile Immunocompromised Renal Transplant Recipient with Allograft Dysfunction: Detection of an Undiagnosed Prostate Abscess by [ 18 F]FDG-PET/CT along with Treatment Response Monitoring. World journal of nuclear medicine 23 (3) (2024)
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors. World journal of nuclear medicine 23 (3) (2024)
Nivedita Chakrabarty, Abhishek Mahajan, Sandip Basu, Anil K D'Cruz
Comprehensive Review of the Imaging Recommendations for Diagnosis, Staging, and Management of Thyroid Carcinoma. Journal of clinical medicine 13 (10) (2024)
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of 131 I-Whole-Body Scintigraphy with Regional SPECT/CT. World journal of nuclear medicine 23 (2) (2024)
Ashwini Chalikandy, Sandip Basu
Middle Ear Cavity and Mastoid Neuroendocrine Tumor Presenting as Otomastoiditis with Cholesteatoma: A Clinicoradiological and Histopathological Correlation. World journal of nuclear medicine 22 (4) (2023)
Ashwini Chalikandy, Sandip Basu
Middle Ear Cavity and Mastoid Neuroendocrine Tumor Presenting as Otomastoiditis with Cholesteatoma: A Clinicoradiological and Histopathological Correlation. World journal of nuclear medicine 22 (4) (2023)
Mahesh Kumar Padwal, Sandip Basu, Bhakti Basu
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors. Current oncology (Toronto, Ont.) 30 (10) (2023)
Aadil Adnan, Sandip Basu
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics (Basel, Switzerland) 13 (13) (2023)
Ashwini Kalshetty, Sandip Basu
Assessment of Pulmonary Metastasis in Differentiated Thyroid Carcinoma: Value of HRCT Correlation with Functional Imaging. World journal of nuclear medicine 22 (2) (2023)
Sonam Suman, Rahul V Parghane, Amit Joshi, Kumar Prabhash, Sanjay Talole, Sandip Basu
Combined 177 Lu-PSMA-617 PRLT and abiraterone acetate versus 177 Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability. The Prostate 81 (15) (2021)
null Kamaldeep, Sarvesh Loharkar, Tapas Das, Sandip Basu, Sharmila Banerjee
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles. Cancer biotherapy & radiopharmaceuticals 37 (3) (2021)
Rahul V Parghane, Vikas Ostwal, Anant Ramaswamy, Manish Bhandare, Vikram Chaudhari, Sanjay Talole, Shailesh V Shrikhande, Sandip Basu
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease. European journal of nuclear medicine and molecular imaging 48 (3) (2020)
Rahul V Parghane, Sanjay Talole, Sandip Basu
131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy. Annals of nuclear medicine 35 (1) (2020)
Sandip Basu, Rahul V Parghane, Sharmila Banerjee
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors? European journal of nuclear medicine and molecular imaging 47 (4) (2019)
Rahul V Parghane, Chinna Naik, Sanjay Talole, Anuja Desmukh, Devendra Chaukar, Sharmila Banerjee, Sandip Basu
Clinical utility of 177 Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity. Head & neck 42 (3) (2019)